ArticlePloS one2022

Association between ustekinumab therapy and changes in specific anti-microbial response, serum biomarkers, and microbiota composition in patients with IBD: A pilot study.

Filip Rob et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.